At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
STTK Shattuck Labs, Inc.
Market Closed 04-04 16:00:00 EDT
0.7330
-0.0800
-9.84%
盘后0.7367
+0.0037+0.50%
19:31 EDT
| High0.8100 | Low0.7100 | Vol125.00K |
| Open0.8100 | D1 Closing0.8130 | Amplitude12.30% |
| Mkt Cap35.11M | Tradable Cap17.72M | Total Shares47.90M |
| T/O92.85K | T/O Rate0.52% | Tradable Shares24.18M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire · 04-02
Shattuck Labs Full Year 2024 Earnings: Misses Expectations
Simply Wall St. · 03-28
Shattuck Labs Inc reports results for the quarter ended December 31 - Earnings Summary
Reuters · 03-27
Shattuck Labs’ SL-325: Promising Preclinical Results and Growth Potential Justify Buy Rating
TIPRANKS · 03-27
Shattuck Labs: Hold Rating Due to Early Pipeline Stages and Lack of Near-Term Catalysts
TIPRANKS · 03-27
BRIEF-Shattuck Labs Q4 Net Income USD -18.679 Million
Reuters · 03-27
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
THOMSON REUTERS · 03-27
Shattuck Labs Inc - Cash Balance of $73 Million Expected to Fund Operations Into 2027
THOMSON REUTERS · 03-27
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire · 03-27
Shattuck Labs Inc expected to post a loss of 32 cents a share - Earnings Preview
Reuters · 03-25
Shattuck Labs Inc expected to post a loss of 32 cents a share - Earnings Preview
Reuters · 03-21
Shattuck Labs Initiated at Outperform by Leerink Partners
Dow Jones · 03-17
Leerink Partners Initiates Shattuck Labs at Outperform With $4 Price Target
MT Newswires Live · 03-17
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones · 03-17
Shattuck Labs Inc expected to post a loss of 32 cents a share - Earnings Preview
Reuters · 03-11
Favourable Signals For Shattuck Labs: Numerous Insiders Acquired Stock
Simply Wall St. · 03-11
Shattuck Labs Inc expected to post a loss of 32 cents a share - Earnings Preview
Reuters · 03-04
Shattuck Labs Inc expected to post a loss of 32 cents a share - Earnings Preview
Reuters · 02-28
Shattuck Labs Inc expected to post a loss of 32 cents a share - Earnings Preview
Reuters · 02-24
H.C. Wainwright Keeps Their Hold Rating on Shattuck Labs (STTK)
TIPRANKS · 02-21
Introduction
Company Name.
Shattuck Labs, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
2020-10-09
Main Business:
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Issue price:
17.00
Invest in Global Markets with Tiger Brokers!Open App